Features of congenital and infantile nephrotic syndrome in Russian children

Introduction. Nephrotic syndrome (NS) with an onset in the first year of life is one of the actual problems in pediatric nephrology due to the limited therapeutic options, the ineffectiveness of immunosuppressive therapy, and inevitable progression to chronic kidney disease (CKD). The basis of congenital NS (CNS) and infantile NS (INS) is a genetically determined pathology of podocytes. The timely verification of such pathology allows avoiding ineffective therapy and helps to predict outcomes. Aim. To determine CNS and INS’s clinical and molecular genetic characteristics in Russian children.

Materials and methods. This study performed molecular genetic testing of 99 children with an early onset of NS.

Results. In children with CNS and INS, the genetic cause of the disease was verified in 85%. Causative nucleotide variants prevailed in the NPHS1, NPHS2, WT1 genes. It became possible to identify the significant nucleotide variants for the Russian group of children. Children with NS at an early age turned out to be resistant to therapy with calcineurin inhibitors, which should be considered when choosing therapy tactics.

Conclusion. We detected the genetic structure of congenital and infantile NS in the Russian Federation during the study. We analyzed the effectiveness of therapy with calcineurin inhibitors and the rate of CKD progression in this group.

Contribution:
Milovanova A.M., Tsygin A.N., Savostyanov K.V. — the concept and design of the study;
Milovanova A.M., Ananin P.V. — collection and processing of material, statistical processing;
Milovanova A.M., Ananin P.V., Vashurina T.V. — text writing;
Pushkov A.A., Zrobok O.I., Ryaposova A.B. — editing.
All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.

Acknowledgement. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Received: December 06, 2021
Accepted: December 17, 2021
Published: December 29, 2021

1. Trautmann A., Lipska-Ziketkiewicz B.S., Schaefer F. Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: The PodoNet registry. Front. Pediatr. 2018; 6: 200. https://doi.org/10.3389/fped.2018.00200

2. Mekahli D., Liutkus A., Ranchin B., Yu A., Bessenay L., Girardin E., et al. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr. Nephrol. 2009; 24(8): 1525–32. https://doi.org/10.1007/s00467-009-1138-5

3. Liu Y., Shi Y., Ren R., Xie J., Wang W., Chen N. Advanced therapeutics in focal and segmental glomerulosclerosis. Nephrology (Carlton). 2018; 23(Suppl. 4): 57–61. https://doi.org/10.1111/nep.13463

4. Sladkov D.G., Savost’yanov K.V., Tsygin A.N., Pushkov A.A., Zhanin I.S., Nikitin A.G., et al. New method of molecular and genetic diagnostics of steroid-resistant nephrotic syndrome. Meditsinskaya genetika. 2016; 15(5): 38–41. (in Russian)

5. Ryzhkova O.P., Kardymon O.L., Prokhorchuk E.B., Konovalov F.A., Maslennikov A.B., Stepanov V.A., et al. Guidelines for the interpretation of massive parallel sequencing variants (update 2018, v2). Meditsinskaya genetika. 2019; 18(2): 3–23. https://doi.org/10.25557/2073-7998.2019.02.3-23 (in Russian)

6. Loymann E., Tsygin A.N., Sarkisyan A.A. Pediatric Nephrology: A Practical Guide [Detskaya nefrologiya: prakticheskoe rukovodstvo]. Moscow: LitTera; 2010. (in Russian)

7. Kari J.A., Montini G., Bockenhauer D., Brennan E., Rees L., Trompeter R.S., et al. Clinico-pathological correlations of congenital and infantile nephrotic syndrome over twenty years. Pediatr. Nephrol. 2014; 29(11): 2173–80. https://doi.org/10.1007/s00467-014-2856-x

8. Bierzynska A., McCarthy H.J., Soderquest K., Sen E.S., Colby E., Ding W.Y., et al. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int. 2017; 91(4): 937–47. https://doi.org/10.1016/j.kint.2016.10.013

9. Machuca E., Benoit G., Nevo F., Tete M.G., Gribouval O., Pawtowski A., et al. Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome. J. Am. Soc. Nephrol. 2010; 21(7): 1209–17. https://doi.org/10.1681/ASN.2009121309

10. Hinkes B.G., Mucha B., Vlangos C.N., Gbadegesin R., Liu J., Hasselbacher K., et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 Genes (NPHS1, NPHS2, WT1 and LAMB2). Pediatrics. 2007; 119(4): e907–19. https://doi.org/10.1542/peds.2006-2164

11. Sharief S.N., Hefni N.A., Alzahrani W.A., Nazer I.I., Bayazeed M.A., Alhasan K.A., et al. Genetics of congenital and infantile nephrotic syndrome. World J. Pediatr. 2019; 15(2): 198–203. https://doi.org/10.1007/s12519-018-00224-0

12. Trautmann A., Bodria M., Ozaltin F., Gheisari A., Melk A., Azocar M., et al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin. J. Am. Soc. Nephrol. 2015; 10(4): 592–600. https://doi.org/10.2215/CJN.06260614

13. Sako M., Nakanishi K., Obana M., Yata N., Hoshii S., Takahashi S., et al. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int. 2005; 67(4): 1248–55. https://doi.org/10.1111/j.1523-1755.2005.00202.x

14. McCarthy H.J., Bierzynska A., Wherlock M., Ognjanovic M., Kerecuk L., Hegde S., et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 2013; 8(4): 637–48. https://doi.org/10.2215/CJN.07200712

15. Tikhomirov E., Averyanova N., Bayazutdinova G., Voznesenskaya T., Tsygin A. Novel human pathological mutations. Gene symbol: NPHS2. Disease: steroid-resistant nephrotic syndrome. Hum. Genet. 2007; 122(5): 549. https://doi.org/10.1007/s00439-007-0423-2

16. Bouchireb K., Boyer O., Gribouval O., Nevo F., Huynh-Cong E., Moriniere V., et al. PHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum. Hum. Mutat. 2014; 35(2): 178–86. https://doi.org/10.1002/humu.22485

17. Lipska B.S., Balasz-Chmielewska I., Morzuch L., Wasielewski K., Vetter D., Borzecka H., et al. Mutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients: founder effect in the Kashubian population. J. Appl. Genet. 2013; 54(2): 327–33. https://doi.org/10.1007/s13353-013-0147-z

18. Kerti A., Csohány R., Szabó A., Árkossy O., Sallay P., Moriniére V., et al. NPHS2 p.V290M mutation in late-onset steroid-resistant nephrotic syndrome. Pediatr. Nephrol. 2013; 28(5): 751–7. https://doi.org/10.1007/s00467-012-2379-2

19. Karle S.M., Uetz B., Ronner V., Glaeser L., Hildebrandt F., Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 2002; 13(2): 388–93. https://doi.org/10.1681/ASN.V132388

20. Cil O., Besbas N., Duzova A., Topaloglu R., Peco-Antić A., Korkmaz E., et al. Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome. Pediatr. Nephrol. 2015; 30(8): 1279–87. https://doi.org/10.1007/s00467-015-3058-x

21. Ozaltin F., Heeringa S., Poyraz C.E., Bilginer Y., Kadayifcilar S., Besbas N., et al. Eye involvement in children with primary focal segmental glomerulosclerosis. Pediatr. Nephrol. 2008; 23(3): 421–7. https://doi.org/10.1007/s00467-007-0695-8

22. Büscher A.K., Beck B.B., Melk A., Hoefele J., Kranz B., Bamborschke D., et al. Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 2016; 11(2): 245–53. https://doi.org/10.2215/CJN.07370715

23. Faul C., Donnelly M., Merscher-Gomez S., Chang Y.H., Franz S., Delfgaauw J., et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 2008; 14(9): 931–8. https://doi.org/10.1038/nm.1857

24. Gipson D.S., Trachtman H., Kaskel F.J., Greene T.H., Radeva M.K., Gassman J.J., et al. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int. 2011; 80(8): 868–78. https://doi.org/10.1038/ki.2011.195

25. Sadowski C.E., Lovric S., Ashraf S., Pabst W.L., Gee H.Y., Kohl S., et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 2015; 26(6): 1279–89. https://doi.org/10.1681/ASN.2014050489

26. Klaassen I., Özgören B., Sadowski C.E., Möller K., van Husen M., Lehnhardt A., et al. Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible. Pediatr. Nephrol. 2015; 30(9): 1477–83. https://doi.org/10.1007/s00467-015-3109-3